Lankacidin C 8-acetate

Catalog No. :
ACCFWC656
CAS No. :
23812-97-7
Molecular Formula :
C27H35NO8
Molecular Weight :
501.58

IUPAC Name:(1S,2R,3E,5E,7S,9E,11E,13S,15R,19R)-13-hydroxy-1,4,10,19-tetramethyl-17,18-dioxo-2-(2-oxopropanamido)-16-oxabicyclo[13.2.2]nonadeca-3,5,9,11-tetraen-7-yl acetate

Lankacidin C 8-acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameLankacidin C 8-acetate
IUPAC Name(1S,2R,3E,5E,7S,9E,11E,13S,15R,19R)-13-hydroxy-1,4,10,19-tetramethyl-17,18-dioxo-2-(2-oxopropanamido)-16-oxabicyclo[13.2.2]nonadeca-3,5,9,11-tetraen-7-yl acetate
Molecular FormulaC27H35NO8
Molecular Weight501.58
SMILESCC(O[C@@H](C/C=C(C)/C=C/[C@@H](O)C[C@@]1([H])O2)/C=C/C(C)=C/[C@@H](NC(C(C)=O)=O)[C@](C([C@@H]1C)=O)(C)C2=O)=O
InChI KeySXLMQJVXWZFRNQ-LDACTNBVSA-N
SynonymLankacidin C 8-acetate;N-[(1S,2R,3E,5E,7S,9E,11E,13S,15R,19R)-7-(Acetyloxy)-13-hydroxy-1,4,10,19-tetramethyl-17,18-dioxo-16-oxabicyclo[13.2.2]nonadeca-3,5,9,11-tetren-2-yl]-2-oxopropanamide;Propanamide, N-[7-(acetyloxy)-13-hydroxy-1,4,10,19-tetramethyl-17,18-dioxo-16-oxabicyclo[13.2.2]nonadeca-3,5,9,11-tetraen-2-yl]-2-oxo-, [1S-(1R*,2S*,3E,5E,7R*,9E,11E,13R*,15S*,19S*)]- (9CI)
CAS No.23812-97-7

Synthetic Route by SureRoute

1. ACCFWC656 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCFWC656 route product structure diagram
    ACCFWC65623812-97-7
Inquiry

2. ACCFWC656 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCFWC656 route product structure diagram
    ACCFWC65623812-97-7
Inquiry

Comments (0)